Sponsored Links
| Cyberonics Announces First Implant Of AspireSR™ Seizure Response Product In European Trial |
 |
 |
 |
| Medical News - Epilepsy | |||
|
Cyberonics, Inc. (Nasdaq: CYBX), a global leader in epilepsy management, announced the first implant of its AspireSR™ seizure response product on April 27, 2011... Read more: Epilepsy News From Medical News Today
|